Markus Perl
Impact in
-
- Cancer, Lipids, and Metabolism
-
- Metabolomics and Mass Spectrometry Studies
- Sphingolipid Metabolism and Signaling
- Gut microbiota and health
- Glycosylation and Glycoproteins Research
Papers in
-
- Hematopoietic Stem Cell Transplantation 3
- Oncology 4
- Cancer Immunotherapy and Biomarkers 2
- CAR-T cell therapy research 2
- Co-authors
- Klaus‐Peter Janssen (3 shared papers)Ludger Johannes (2 shared papers)Ulrich Nitsche (2 shared papers)Elisa Benedetti (1 shared paper)Marcus Höring (1 shared paper)Josef Ecker (1 shared paper)Alida S. D. Kindt (1 shared paper)Gerhard Liebisch (1 shared paper)
- Journals
- Cell Reports Medicine (2 papers)Gastroenterology (1 paper)Molecular Cancer Therapeutics (1 paper)Aesthetic Plastic Surgery (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Markus Perl
14 papers receiving 305 citations
Peers
Comparison fields: 5 of 42
- Cancer Research 57
- Molecular Biology 142
- Immunology 37
- Oncology 38
- Hematology 20
Countries citing papers authored by Markus Perl
This map shows the geographic impact of Markus Perl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Perl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Perl more than expected).
Fields of papers citing papers by Markus Perl
This network shows the impact of papers produced by Markus Perl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Perl. The network helps show where Markus Perl may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Perl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 120 | |
| 2 | 2016 | 49 | |
| 3 | 2020 | 42 | |
| 4 | 2025 | 23 | |
| 5 | 2023 | 19 | |
| 6 | 2025 | 13 | |
| 7 | 2024 | 9 | |
| 8 | 2020 | 8 | |
| 9 | 2023 | 6 | |
| 10 | 2025 | 6 | |
| 11 | 2025 | 4 | |
| 12 | 2025 | 4 | |
| 13 | 2022 | 2 | |
| 14 | 2024 | 1 |
About Markus Perl
Markus Perl is a scholar working on Hematology, Oncology, Molecular Biology, Immunology and Pharmacy, having authored 14 papers that have together received 306 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Gut microbiota and health (2 papers), CAR-T cell therapy research (2 papers), Toxin Mechanisms and Immunotoxins (1 paper), Legal Rights and Human Rights (1 paper), Inflammasome and immune disorders (1 paper) and Medical and Health Sciences Research (1 paper). The work is most often cited by research in Cancer Research (57 citations), Molecular Biology (142 citations), Immunology (37 citations), Oncology (38 citations) and Hematology (20 citations). Markus Perl has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Klaus‐Peter Janssen, Ludger Johannes, Ulrich Nitsche, Elisa Benedetti, Marcus Höring, Josef Ecker, Alida S. D. Kindt, Gerhard Liebisch, Jan Krumsiek and Yuting Wang. Their work appears in journals such as Cell Reports Medicine, Gastroenterology, Molecular Cancer Therapeutics, Aesthetic Plastic Surgery and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.